1 | Drug repurposing of antidiabetic agents against COVID-19’s 3CLpro enzyme | |
Page 1-12 | ||
Heba S. Rateb; Ahmed M. Nonn; Omar K. Bakr; Lina M. Amin | ||
2 | Green and Conventional Synthetic Strategies for Quinoxaline Derivatives: Toward a Sustainable Future | |
Page 13-25 | ||
Aya A. Abdelaziz; Ahmed Moustafa; Youssif Ibrahim; Noha Ryad | ||
3 | Advancing Nanoparticle Production: Scaling Up Techniques, Challenges, and Future Perspectives in Pharmaceutical Applications | |
Page 26-39 | ||
Rehab Abdelmonem; MennaAllah Ayman; Sara Emad lofty; Yara Ezzat; Jaklin momtaz Nabeah; Hager Mohamed; Mohamed safwat; Abdelrahman Abdelzaher; alaa AboAlfa; Mohamed Abdelkhalek; Roaa mohamed ali; Salma samy; Mai Hany Fathy; Aliaa Abdelati; Menna Abdellatif; Mahmoud Eltahan | ||
4 | Recently Identified MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Acute coronary syndrome | |
Page 40-71 | ||
Doaa Fayez Saeed; Hager K. Rashwan; Doha AbdElnasser; Reham Ali; Hager Yehia; Reem Mohamed; Reham AbdElsalam; Sara Elsayed; Nada Mohamed Omar; Marwa Mohanad | ||
5 | Formulation of grape seed oil and hibiscus extract for treatment of acne: optimization using D-optimal design and in vitro characterization | |
Page 72-80 | ||
Abeer A. Musallam; Yasmina Elmahboub; Kristina Zarif Attalla; Omar Elfarouk; Norhan Aly; Lydia Bligh; Marim Essam; Mayar Ali; Eman Abdelhamied; Mohamed Kotb; Rania M. Abd El Galil; Reem A. Aldeeb | ||